Collaboration - August 10, 2015
MedImmune in strategic collaboration with Inovio Pharmaceuticals
MedImmune, AstraZeneca’s global biologics research and development arm, has entered into a license agreement and collaboration with Inovio Pharmaceuticals, a biotechnology company developing DNA-based immunotherapies for cancer and infectious diseases. Under the agreement, MedImmune will acquire exclusive rights to Inovio’s INO-3112 immunotherapy, which targets cancers caused by human papillomavirus (HPV) types 16 and 18. INO-3112, which […]
Intellectual Property - June 17, 2013
Human genes can’t be patented
On June 13, the US Supreme Court ruled unanimously that natural human genes cannot be patented. Human genes may not be patented, but artificially copied DNA however can be claimed as intellectual property, according to the decision. The ruling concerns a challenge to patents held by biotechnology company, Myriad Genetics Inc., on two genes that […]
